13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q2 2021. See the latest, Q2 2026 →
Reported value
$32.98B
−1.8% on the quarter before
Positions
88
23 new · 29 sold out
Top 10
36.7%
of the value
Est. gain
+$1.27B
on stocks held all quarter
Est. return
+5.4%
on those stocks since Q1 2021
Positions as of Jun 30, 2021, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2021. Striped tiles are options.
Largest buys
Since Q1 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amazon~$1.01BAdded · 1.7% → 4.9%+293,150 shares
- Figs Inc~$748.6MNew · 0.0% → 2.3%+14,942,689 shares
- Jd.Com Inc~$657.7MNew · 0.0% → 2.0%+8,241,079 shares
- Coupa Software Inc~$473.1MAdded · 1.4% → 2.9%+1,805,064 shares
- General Electric Co~$419.2MAdded · 2.4% → 3.7%+31,140,834 shares
- Bristol-Myers Squibb Co~$409.1MAdded · 1.0% → 2.3%+6,122,279 shares
- Icici Bank Limited~$360.3MNew · 0.0% → 1.1%+21,070,884 shares
- ServiceNow~$318.7MAdded · 1.3% → 2.5%+579,850 shares
- Humana Inc~$260.4MNew · 0.0% → 0.8%+588,285 shares
- Brookfield Asset Mgmt Inc~$210.6MNew · 0.0% → 0.6%+4,130,609 shares
Largest sells
Since Q1 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$1.05BCut · 6.0% → 3.8%−3,860,680 shares
- Bk Of America Corp~$995.2MCut · 3.6% → 0.9%−24,138,200 shares
- Alphabet~$976.0MCut · 2.8% → 0.4%−399,721 shares
- Abcellera Biologics Inc~$648.1MSold out · 1.9% → 0.0%−19,083,744 shares
- Oreilly Automotive Inc~$541.1MSold out · 1.6% → 0.0%−1,066,676 shares
- Unitedhealth Group Inc~$513.5MCut · 3.4% → 2.2%−1,282,224 shares
- Moody's Corporation~$512.4MSold out · 1.5% → 0.0%−1,716,016 shares
- Nuance Communications Inc~$483.9MSold out · 1.4% → 0.0%−11,088,603 shares
- Otis Worldwide Corp~$467.8MSold out · 1.4% → 0.0%−6,834,220 shares
- Visa Inc.~$425.4MCut · 2.5% → 1.6%−1,819,346 shares
Holdings
As of Jun 30, 2021. Changes are in shares against Mar 31, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AmazonCOM · shares +162% · price +11.2% | 4.9% | $1.63B | +$62.7M | ||||||||
| Bridgebio Pharma IncCOM · shares 0% · price −1.0% | 4.9% | $1.62B | −$17.0M | ||||||||
| Fidelity Natl Information SvCOM · shares −4.1% · price +0.8% | 4.0% | $1.30B | +$9.8M | ||||||||
| MicrosoftCOM · shares −45% · price +14.9% | 3.8% | $1.26B | +$163.5M | ||||||||
| General Electric CoCOM · shares +51% · price +2.5% | 3.7% | $1.24B | +$20.0M | ||||||||
| Adaptive Biotechnologies CorCOM · shares 0% · price +1.5% | 3.7% | $1.23B | +$18.0M | ||||||||
| T-Mobile Us IncCOM · shares −27% · price +15.6% | 3.3% | $1.09B | +$147.4M | ||||||||
| Palo Alto NetworksCOM · shares +5.3% · price +15.2% | 3.0% | $979.7M | +$122.9M | ||||||||
| Coupa Software IncCOM · shares +101% · price +3.0% | 2.9% | $943.6M | +$13.7M | ||||||||
| Fortive CorpCOM · shares +5.3% · price −1.3% | 2.5% | $821.4M | −$10.1M | ||||||||
| Centene Corp DelCOM · shares +2.0% · price +14.1% | 2.5% | $816.8M | +$99.0M | ||||||||
| ServiceNowCOM · shares +64% · price +9.9% | 2.5% | $814.6M | +$44.6M | ||||||||
| Chubb LimitedCOM · shares +18% · price +0.6% | 2.4% | $782.0M | +$4.1M | ||||||||
| Bristol-Myers Squibb CoCOM · shares +118% · price +5.8% | 2.3% | $756.3M | +$19.2M | ||||||||
| Figs IncCL A · shares New | 2.3% | $748.6M | — | ||||||||
| Fleetcor Technologies IncCOM · shares +9.1% · price −4.7% | 2.2% | $735.6M | −$33.1M | ||||||||
| Unitedhealth Group IncCOM · shares −42% · price +7.6% | 2.2% | $720.3M | +$51.0M | ||||||||
| MetaCL A · shares −14% · price +18.1% | 2.1% | $706.1M | +$108.0M | ||||||||
| Api Group CorpCOM STK · shares 0% · price +1.0% | 2.1% | $696.3M | +$7.0M | ||||||||
| Aon PlcSHS CL A · shares +35% · price +3.8% | 2.1% | $693.1M | +$18.6M | ||||||||
| Jd.Com IncSPON ADR CL A · shares New | 2.0% | $657.7M | — | ||||||||
| Boston Scientific CorpCOM · shares −26% · price +10.6% | 1.7% | $569.4M | +$54.7M | ||||||||
| Guardant Health IncCOM · shares +46% · price −18.6% | 1.6% | $528.6M | −$83.1M | ||||||||
| Visa Inc.COM CL A · shares −45% · price +10.4% | 1.6% | $518.9M | +$49.0M | ||||||||
| Thermo Fisher Scientific IncCOM · shares +17% · price +10.5% | 1.5% | $510.2M | +$41.4M | ||||||||
| Total · 88 positions | 100% | $32.98B | +$1.27B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2021 to Q2 2021: 65 stocks held throughout, up $1.27B (+5.4%).
- Microsoft+$163.5M+15%
- T-Mobile Us Inc+$147.4M+16%
- Palo Alto Networks+$122.9M+15%
- Meta+$108.0M+18%
- Centene Corp Del+$99.0M+14%
- Pharvaris N V−$23.7M−35%
- Edgewise Therapeutics Inc−$30.5M−34%
- Fleetcor Technologies Inc−$33.1M−5%
- 4d Molecular Therapeutics In−$76.0M−44%
- Guardant Health Inc−$83.1M−19%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |